Jennifer O Lam1, Catherine Lee1, Paola Gilsanz1, Craig E Hou2, Wendy A Leyden1, Derek D Satre1,3, Jason A Flamm4, William J Towner5, Michael A Horberg6, Michael J Silverberg1. 1. Division of Research, Kaiser Permanente Northern California, Oakland. 2. South San Francisco Medical Center, Kaiser Permanente Northern California, South San Francisco. 3. Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco. 4. Sacramento Medical Center, Kaiser Permanente Northern California, Sacramento. 5. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California. 6. Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.
Abstract
OBJECTIVE: To compare dementia incidence and prevalence after age 50 years by HIV status. DESIGN: Observational cohort, 2000-2016. METHODS: People with HIV (PWH) on antiretroviral therapy (ART) and demographically similar people without HIV (PWoH), all aged 50 years and older, were identified from Kaiser Permanente healthcare systems in Northern California, Southern California, and Mid-Atlantic States (Maryland, Virginia, Washington DC). Dementia diagnoses were obtained from electronic health records. Incidence and prevalence of dementia, overall and by time period (i.e. 2000-2002, 2003-2004, …, 2015-2016), were calculated using Poisson regression. Trends were examined using Joinpoint regression. Rate ratios were used to compare dementia by HIV status with adjustment for sociodemographics, substance use, and clinical factors. RESULTS: The study included 13 296 PWH and 155 354 PWoH (at baseline: for both, mean age = 54 years, 89% men; for PWH, 80% with HIV RNA <200 copies/ml). From 2000 to 2016, overall incidence of dementia was higher among PWH [adjusted incidence rate ratio (aIRR) = 1.80, 95% confidence interval (CI) = 1.60-2.04]. Dementia incidence decreased among both PWH and PWoH (-8.0 and -3.1% per period, respectively) but remained higher among PWH in the most recent time period, 2015-2016 (aIRR = 1.58, 95% CI = 1.18-2.12). The overall prevalence of dementia from 2000 to 2016 was higher among PWH [adjusted prevalence ratio (aPR) = 1.86, 95% CI = 1.70-2.04] and was also higher among PWH in 2015-2016 (aPR = 1.75, 95% CI = 1.56-1.97). CONCLUSION: Reductions in dementia incidence are encouraging and may reflect ART improvement, but PWH are still more likely to have dementia than PWoH. Monitoring the burden of dementia among PWH is important as this population ages.
OBJECTIVE: To compare dementia incidence and prevalence after age 50 years by HIV status. DESIGN: Observational cohort, 2000-2016. METHODS: People with HIV (PWH) on antiretroviral therapy (ART) and demographically similar people without HIV (PWoH), all aged 50 years and older, were identified from Kaiser Permanente healthcare systems in Northern California, Southern California, and Mid-Atlantic States (Maryland, Virginia, Washington DC). Dementia diagnoses were obtained from electronic health records. Incidence and prevalence of dementia, overall and by time period (i.e. 2000-2002, 2003-2004, …, 2015-2016), were calculated using Poisson regression. Trends were examined using Joinpoint regression. Rate ratios were used to compare dementia by HIV status with adjustment for sociodemographics, substance use, and clinical factors. RESULTS: The study included 13 296 PWH and 155 354 PWoH (at baseline: for both, mean age = 54 years, 89% men; for PWH, 80% with HIV RNA <200 copies/ml). From 2000 to 2016, overall incidence of dementia was higher among PWH [adjusted incidence rate ratio (aIRR) = 1.80, 95% confidence interval (CI) = 1.60-2.04]. Dementia incidence decreased among both PWH and PWoH (-8.0 and -3.1% per period, respectively) but remained higher among PWH in the most recent time period, 2015-2016 (aIRR = 1.58, 95% CI = 1.18-2.12). The overall prevalence of dementia from 2000 to 2016 was higher among PWH [adjusted prevalence ratio (aPR) = 1.86, 95% CI = 1.70-2.04] and was also higher among PWH in 2015-2016 (aPR = 1.75, 95% CI = 1.56-1.97). CONCLUSION: Reductions in dementia incidence are encouraging and may reflect ART improvement, but PWH are still more likely to have dementia than PWoH. Monitoring the burden of dementia among PWH is important as this population ages.
Authors: A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna Journal: Neurology Date: 2007-10-03 Impact factor: 9.910
Authors: Daniel B Klein; Wendy A Leyden; Lanfang Xu; Chun R Chao; Michael A Horberg; William J Towner; Leo B Hurley; Julia L Marcus; Charles P Quesenberry; Michael J Silverberg Journal: Clin Infect Dis Date: 2015-01-16 Impact factor: 9.079
Authors: J C McArthur; D R Hoover; H Bacellar; E N Miller; B A Cohen; J T Becker; N M Graham; J H McArthur; O A Selnes; L P Jacobson Journal: Neurology Date: 1993-11 Impact factor: 9.910
Authors: Lucette A Cysique; Robert K Heaton; Jody Kamminga; Tammy Lane; Thomas M Gates; Danielle M Moore; Emma Hubner; Andrew Carr; Bruce J Brew Journal: J Neurovirol Date: 2014-04-03 Impact factor: 2.643
Authors: Julia L Marcus; Wendy A Leyden; Stacey E Alexeeff; Alexandra N Anderson; Rulin C Hechter; Haihong Hu; Jennifer O Lam; William J Towner; Qing Yuan; Michael A Horberg; Michael J Silverberg Journal: JAMA Netw Open Date: 2020-06-01
Authors: Htein Linn Aung; Maral Aghvinian; Hetta Gouse; Reuben N Robbins; Bruce J Brew; Limin Mao; Lucette A Cysique Journal: AIDS Behav Date: 2020-10-06
Authors: Jennifer O Lam; Wendy A Leyden; Thomas K Leong; Michael A Horberg; Kristi Reynolds; Andrew P Ambrosy; Harshith R Avula; Rulin C Hechter; William J Towner; Suma Vupputuri; Alan S Go; Michael J Silverberg Journal: J Acquir Immune Defic Syndr Date: 2022-10-01 Impact factor: 3.771
Authors: Mattia Trunfio; Cristiana Atzori; Marta Pasquero; Alessandro Di Stefano; Daniela Vai; Marco Nigra; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno Journal: Viruses Date: 2022-04-04 Impact factor: 5.818
Authors: Bernadette Jakeman; Alexandra U Scherrer; Katharine E A Darling; Jose Damas; Melanie Bieler-Aeschlimann; Barbara Hasse; Ladina Schlosser; Anna Hachfeld; Klemens Gutbrod; Philip E Tarr; Alexandra Calmy; Frederic Assal; Ursula Kunze; Marcel Stoeckle; Patrick Schmid; Gianina Toller; Stefania Rossi; Caroline di Benedetto; Renaud du Pasquier; Matthias Cavassini; Catia Marzolini Journal: Open Forum Infect Dis Date: 2022-09-02 Impact factor: 4.423